Cryo-Cell International, Inc.

4.4010-0.11 (-2.5%)
Oct 29, 3:48:22 PM EDT · NYSE American · CCEL · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
35.45M
P/E (TTM)
-
Basic EPS (TTM)
-0.06
Dividend Yield
0.14%

Recent Filings

About

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

CEO
Mr. David I. Portnoy
IPO
4/4/1994
Employees
82
Sector
Healthcare
Industry
Medical Care Facilities